Regulatory Update – Week of April 1, 2024
Courtney Savage
April 5, 2024
No Comments
The regulatory update for this week features finalized payment policies for Medicare Advantage and Part D programs, alongside ongoing negotiations with pharmaceutical companies. Additionally, the FDA approves Abbott’s TriClip™ device for repairing leaky tricuspid heart valves amidst a Senate hearing addressing concerns about private equity’s impact on healthcare.
Recent Comments